M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.399 PLN -9.11% Market Closed
Market Cap: 27.1m PLN
Section:
 

Relative Value

The Relative Value of one MDB stock under the Base Case scenario is hidden PLN. Compared to the current market price of 0.399 PLN, Medicofarma Biotech SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

97.1
P/S
P/S
Price to Sales
97.1
vs History
1
vs Industry
11
Median 3Y
37.2
Median 5Y
18.1
Industry
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-15.3
Median 5Y
-33.8
Industry
31.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
29
Median 3Y
-12.6
Median 5Y
-17.9
Industry
19.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
20
Median 3Y
-87.8
Median 5Y
-179.2
Industry
26.9
More Details
4.9
P/B
P/B
Price to Book Value
4.9
vs History
25
vs Industry
45
Median 3Y
5.8
Median 5Y
6.1
Industry
2.8
More Details
97.1
EV/S
EV/S
Enterprise Value to Sales
97.1
vs History
1
vs Industry
10
Median 3Y
37.2
Median 5Y
18
Industry
4
More Details
268.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
268.4
vs History
1
vs Industry
14
Median 3Y
67.5
Median 5Y
53.2
Industry
8.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
9
Median 3Y
-29
Median 5Y
-50.2
Industry
18.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-16.5
Median 5Y
-34
Industry
24.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
31
Median 3Y
-12.6
Median 5Y
-17.9
Industry
20.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
27
Median 3Y
-26
Median 5Y
-58.4
Industry
26.9
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
58
vs Industry
51
Median 3Y
4.2
Median 5Y
4.8
Industry
2.3
More Details

Multiples Across Competitors

MDB Competitors Multiples
Medicofarma Biotech SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Medicofarma Biotech SA
WSE:MDB
27.1m PLN 97.1 -8.5 -19.1 -9.1
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 382.2 4 527.2 1 327.9 2 667.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.7B USD 5.1 34.1 24.2 31.3
US
Danaher Corp
NYSE:DHR
162.7B USD 6.7 46.5 24.9 37.7
CH
Lonza Group AG
SIX:LONN
36.9B CHF 5.2 50.4 38.4 38.4
US
Agilent Technologies Inc
NYSE:A
39.1B USD 5.6 30 23.2 27.7
US
IQVIA Holdings Inc
NYSE:IQV
38.4B USD 2.4 29.9 14.5 21.8
CN
WuXi AppTec Co Ltd
SSE:603259
259.2B CNY 5.8 17.3 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD 7.3 34.5 24.9 27.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR 6.9 76.7 27.3 44.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
PL
M
Medicofarma Biotech SA
WSE:MDB
Average EV/EBITDA: 154.2
Negative Multiple: -19.1 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 327.9
5%
265.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
24.2
6%
4
US
Danaher Corp
NYSE:DHR
24.9
5%
5
CH
Lonza Group AG
SIX:LONN
38.4
18%
2.1
US
Agilent Technologies Inc
NYSE:A
23.2
13%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
14.5
8%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
24.9
4%
6.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.3
19%
1.4

See Also

Summary
MDB intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDB stock valuation using valuation multiples.
Wall Street Estimates
MDB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.